Security Snapshot

Senti Biosciences, Inc. - Common Stock, $0.0001 par value (SNTI) Institutional Ownership

CUSIP: 81726A100

13F Institutional Holders and Ownership History from Q2 2022 to Q4 2025

Latest Period

Q4 2025

Institutions Reporting

0

Shares (Excl. Options)

0

Price

Save this security research path

Keep this CUSIP in your research flow, then return after the next filing cycle to check what changed.

Create free account to save this research Review latest holder period
Type / Class
Equity / Common Stock, $0.0001 par value
Symbol
SNTI on Nasdaq
Shares outstanding
31,203,430
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
0
Total reported value
$0
Share change
-253,755
Value change
-$357,795
Number of holders
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Sponsored

Quick Takeaways

  • SNTI - Senti Biosciences, Inc. - Common Stock, $0.0001 par value is tracked under CUSIP 81726A100.
  • 0 institutions reported positions in Q4 2025.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 1 to 0 between Q3 2025 and Q4 2025.
  • Reported value moved from $357,795 to $0.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Official SEC Source

Backed by Form 13F

Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.

See Original Filing

Investment Quick Answers

What is CUSIP 81726A100?
CUSIP 81726A100 identifies SNTI - Senti Biosciences, Inc. - Common Stock, $0.0001 par value in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Senti Biosciences, Inc. - Common Stock, $0.0001 par value (SNTI) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BAYER HEALTHCARE LLC 20% $21,561,396 6,142,848 Bayer HealthCare LLC 10 Mar 2025
New Enterprise Associates 15, L.P. 12% 3,775,615 New Enterprise Associates 15, L.P. 27 Mar 2026
Lonsdale Joe 1% 253,755 8VC GP I, LLC 31 Mar 2025

As of 31 Dec 2025, 0 institutional investors reported holding 0 shares of Senti Biosciences, Inc. - Common Stock, $0.0001 par value (SNTI). This represents 0% of the company’s total 31,203,430 outstanding shares.

Institutional Holders of Senti Biosciences, Inc. - Common Stock, $0.0001 par value (SNTI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 0 $0 -$357,795 0
2025 Q3 253,755 $357,795 $1.41 1
2025 Q2 253,755 $535,423 $2.11 1
2025 Q1 253,755 $852,617 $3.36 1
2024 Q4 253,755 $890,680 -$108,588 $3.51 1
2024 Q3 301,803 $682,074 -$3,229,173 $2.26 2
2024 Q2 7,852,373 $2,167,022 -$200,934 $0.28 18
2024 Q1 10,994,171 $4,145,409 -$257,675 $0.38 27
2023 Q4 11,461,121 $7,564,707 -$1,232,771 $0.66 25
2023 Q3 12,038,399 $5,018,240 -$89,453 $0.41 24
2023 Q2 12,200,284 $7,637,336 -$267,542 $0.63 27
2023 Q1 12,610,070 $14,256,476 +$192,588 $1.18 24
2022 Q4 12,403,151 $16,580,774 -$1,583,124 $1.41 26
2022 Q3 13,467,057 $27,830,384 +$3,545,876 $2.17 22
2022 Q2 11,903,638 $22,079,000 +$22,079,000 $1.96 18

Sponsored